Last updated 2026-07-20
- Raised $10M Series C led by iGan Partners, Jun 2024
- Raised $500k grant, Mar 2023
- Raised $2.5M Series B led by iGan Partners, Feb 2023
Total raised
$13.6M
Last: Undisclosed Round 2024-07
Stage
Series A
Founded
2015
Headcount
33
HQ
Toronto, Canada
Sector
Health Tech & Life Sciences
About
RetiSpec is a medical imaging company that aims to enable widespread early and accurate detection of neurodegenerative disease markers through a simple eye exam. The company's AI solutions, applied to non-invasive retinal images, provide real-time results at the point of care. RetiSpec's first clinically validated AI is intended to predict amyloid burden to aid in the evaluation of individuals for Alzheimer's disease. The company's patented technology harnesses hyperspectral imagery in synergy with machine learning to allow for rapid, simple, and cost-effective identification of Alzheimer's biomarkers years before the emergence of clinical symptoms. RetiSpec's AI solutions are currently available for Research Use Only.
Funding history · 5 rounds · $13.6M total
2024-06
C Round
$10.0M
★ iGan PartnersGentex CorporationVerge HealthTech Fund
2023-03
Grant
$500K
2023-02
B Round
$2.5M
★ iGan Partners
2020-04
A Round
Undisclosed
★ iGan Partners
2019-09
Seed
$500K
★ Alzheimers Drug Discovery Foundation
Headcount over time
From 21 (2022-12) to 34 (2026-03) · +13 (+62%) · 14 points · source: Finder history + radar grounding
Q&A
- What is RetiSpec's primary focus?
- RetiSpec is a medical imaging company developing a noninvasive eye scan tool for the early detection of Alzheimer's disease biomarkers.
- When was RetiSpec founded?
- RetiSpec was founded in June 2016.
- How many employees does RetiSpec have?
- RetiSpec has 32 employees, falling within the 11-50 employee bucket.
- What is RetiSpec's total funding to date?
- RetiSpec has raised a total of $13,550,000 USD.
- When was RetiSpec's most recent funding round and who were the lead investors?
- RetiSpec's most recent funding round occurred in July 2024, raising $10,000,000 USD. iGan Partners and Gentex Corporation were among the investors.
- Which technologies does RetiSpec utilize in its product?
- RetiSpec utilizes Artificial Intelligence, Image Recognition, and Machine Learning in its technology.
- Does RetiSpec hold any patents?
- Yes, RetiSpec holds one patent for its technology.
- Who is a co-founder and COO of RetiSpec?
- Roy Kirshon is a Co-founder and COO of RetiSpec.
Team · 2
Eliav Shaked
Founder · Co-Founder & CEO
Ducovny Tamir
Founder · Former Co-Founder & CTO
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareDigital Medical Diagnostics
Technologies
Artificial IntelligenceImage RecognitionMachine Learning
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2BB2C
Highlights
1 PatentsVerified
Tags
imagingmachine-learningearly-detectioncomputer-visiondigital-healthcareneurologyalzheimers-diseasenon-invasivediagnosticsbiomarkers
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | retispec.com |
|---|---|
| linkedin.com/company/17875841 |
Identifiers & details
| Legal name | RetiSpec Inc. |
|---|---|
| Founded | 2015 |
| Employees (exact) | 33 |
| Offices | Toronto |
Radar intelligence
Patents
| EPO | 6 |
|---|
Publications (Crossref)
| Works | 3 |
|---|
Web history (Wayback)
| Domain | retispec.com |
|---|
Certificate / subdomain footprint
| Subdomains | 2 |
|---|